DJO Global, Inc., a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, announced the appointment of Susan Crawford as the company’s new chief financial officer in the April 15 press release.
Crawford joins DJO Global from Life Technologies Corporation, where she most recently served in a global leadership role as vice president of Business Transformation, responsible for integrating newly acquired companies and engineering business processes throughout the broader organization. Crawford also assisted the Life Technologies Board of Directors with evaluating strategic options for the company. Life Technologies was acquired in February 2014, by Thermo Fisher Scientific for approximately $13.6 billion in equity value.
Prior to that role, Crawford served as Vice President of Corporate Finance Planning and Analysis, responsible for providing finance leadership on the company’s growth strategy, forecasting and analysis, supply chain productivity and financial modeling for mergers and acquisitions. Prior to joining Life Technologies in 2005, Crawford held CFO positions at companies including RealNames and POWERTV, as well as head of Investor Relations and Financial Planning at Covad Communications, where she demonstrated a proven track record and ability to develop and lead top performing finance teams. Crawford received a bachelor’s degree in accounting from Rollins College and an MBA from the University of Central Florida.
Asked what past role has most prepared her for this new position, Crawford told OTW, “I would say it was a combination of roles, the VP of Finance and Investor Relations at Covad Communications and VP of Finance at Invitrogen; both required a hands-on approach to enhance financial capabilities, processes and systems.”
